Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBRAM.L Regulatory News (BRAM)

  • There is currently no data for BRAM

Trading update

21 Jul 2009 07:00

RNS Number : 9855V
Brammer PLC
21 July 2009
 



FROM CITIGATE DEWE ROGERSON FOR

PRESS RELEASE 

FOR RELEASE 07:00 21 July 2009 

Brammer plc

Trading Update

Strategy Continues to Provide Resilience

Brammer plc, the leading pan European added value technical distributor provides the following trading update ahead of its interim results announcement on 28 August 2009.

Trading

Trading in the period 1 January to 30 June 2009 has reflected the difficult trading conditions prevailing in most of the Company's markets. Overall, first half 2009 sales at actual currency rates are down 10.5%, although there were 2 more working days in the comparable 2008 period . Key account sales and industry sector focus strategy continues to provide resilience to these difficult trading conditions. On a sales per working day basis (SPWD), at actual currency rates, sales are down 8.5%. Excluding the year on year effect of acquisitions, SPWD at actual rates are down 10.0%. Excluding the benefits of currency and acquisitions, SPWD were down 17.8%.

 

Gross profit margins continue to be maintained at similar levels to last year. As mentioned in our IMS on 19 May, management has implemented significant cost reduction programmes in all territories and these actions continue to be executed in line with our expectations. Based on measures completed and initiated so far, we expect reported sales, distribution and administration costs, at constant currency, to be around £6 million lower in the first half of 2009 and at least £12 million lower for the full year than in the comparable 2008 periods. We anticipate the cash cost of these restructuring measures will represent a payback of less than one year and this will be taken as an exceptional cost. We exceeded our first half inventory reduction target, reducing inventory by £19 million; net inventory at the period end was £72 million. We continue to pay close attention to working capital and cash management, and we expect reported net debt at the half year will be approximately £69 million, down £15 million on 31 December 2008, including a currency benefit of about £10 million. Banking facilities, which are secured until 2012, remain comfortably in excess of the group's net debt, and we continue to operate within the terms of those facilities.

Corporate Broker 

RBS Hoare Govett Limited has today been appointed as sole broker and financial adviser.

Outlook

Sales in May and June in most territories were at a similar level compared with March and April, suggesting we have reached stability, albeit at a lower level than for the comparable period last year. There are some signs of increasing demand from our automotive and 'Tier One' customers, and we expect to see the benefit of a significant number of both national and European key account contract wins in the second half. The Board intends to continue its focus on cost control, cash flow and driving greater efficiencies from the business, whilst continuing to support our key growth drivers.

We are confident that our strategy of focusing on key accounts, insites and cross selling throughout Europe to drive profitable market share gains remains sound for the medium and longer term, and that Brammer will be able to take advantage of the opportunities available when the economic environment improves.

 

Enquiries: Brammer plc 0161 902 5572

David Dunn, Chairman

Ian Fraser, Chief Executive 

Paul Thwaite, Finance Director

Issued: Citigate Dewe Rogerson Ltd 020 7638 9571

Martin Jackson/Nicola Smith 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKBLFLKDBFBBX
Date   Source Headline
29th Jul 20162:29 pmRNSDirectorate Change
29th Jul 201610:07 amRNSDirector Declaration
6th Jul 201612:48 pmRNSDirectorate Change
4th Jul 20163:04 pmRNSBlock listing Interim Review
1st Jul 201612:05 pmRNSHolding(s) in Company
1st Jul 201611:52 amRNSHolding(s) in Company
30th Jun 20165:39 pmRNSHolding(s) in Company
30th Jun 201610:28 amRNSHolding(s) in Company
29th Jun 20167:00 amRNSTrading Update
1st Jun 201611:39 amRNSDirectorate
31st May 20162:22 pmRNSHolding(s) in Company
13th May 20161:43 pmRNSResult of AGM
13th May 20167:00 amRNSAnnual General Meeting Trading Update
4th May 201610:18 amRNSHolding(s) in Company
4th Apr 20164:51 pmRNSDirector/PDMR Shareholding
31st Mar 201611:36 amRNSHolding(s) in Company
24th Mar 20163:39 pmRNSAnnual Financial Report
17th Mar 20163:43 pmRNSDirector/PDMR Shareholding
15th Mar 20163:51 pmRNSDirector/PDMR Shareholding
9th Mar 20163:33 pmRNSDirector/PDMR Shareholding
9th Mar 201610:26 amRNSDividend Payment
8th Mar 20167:02 amRNSAppointment of New Executive Director
8th Mar 20167:01 amRNSAppointment of Group Finance Director
8th Mar 20167:00 amRNSPreliminary Results
25th Feb 201611:56 amRNSDirector Declaration
16th Feb 201611:16 amRNSHolding(s) in Company
12th Feb 201611:58 amRNSHolding(s) in Company
20th Jan 20165:08 pmRNSHolding(s) in Company
19th Jan 20167:00 amRNSNotice of Results
12th Jan 20162:50 pmRNSHolding(s) in Company
7th Jan 20163:18 pmRNSHolding(s) in Company
7th Jan 201611:54 amRNSHolding(s) in Company
5th Jan 201610:01 amRNSBlocklisting Interim Review
4th Jan 201610:34 amRNSHolding(s) in Company
24th Dec 20151:15 pmRNSDirector/PDMR Shareholding
23rd Dec 201510:40 amRNSDirector/PDMR Shareholding
21st Dec 201510:00 amRNSHolding(s) in Company
16th Dec 20154:38 pmRNSDirectorate Change
9th Dec 201510:10 amRNSDirector/PDMR Shareholding
4th Dec 20153:00 pmRNSHolding(s) in Company
2nd Dec 201512:22 pmRNSHolding(s) in Company
27th Nov 20154:02 pmRNSHolding(s) in Company
20th Nov 20155:13 pmRNSDirector/PDMR Shareholding
11th Nov 20157:00 amRNSTrading Update
9th Nov 20152:40 pmRNSHolding(s) in Company
4th Nov 20152:11 pmRNSHolding(s) in Company
2nd Nov 201511:05 amRNSHolding(s) in Company
27th Oct 201511:39 amRNSDirector/PDMR Shareholding
13th Aug 20152:39 pmRNSDirector/PDMR Shareholding
13th Aug 20159:45 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.